Shares of ad verification company Integral Ad Science (NASDAQ:IAS) jumped 3.2% in the afternoon session after the stock gained ground amid a broader market rally as investors anticipated a busy week ...

In the last three months, 4 analysts have published ratings on Integral Ad Science Holdi (NASDAQ:IAS), offering a diverse range of perspectives from bullish to bearish. The following table summarizes ...

Revenue for Q4 2024 grew 14% to $153 million, with an adjusted EBITDA margin of 40%. Full-year 2024 revenue reached $530.1 million, marking a 12% increase with a 36% adjusted EBITDA margin. CEO Lisa ...

Certification Demonstrates IAS's Commitment to the Highest Standards of Governance and Responsible Business Practices NEW YORK, Dec. 16, 2024 /PRNewswire/ -- Integral Ad Science (IAS), a leading ...

In the latest quarter, 4 analysts provided ratings for Integral Ad Science Holdi (NASDAQ:IAS), showcasing a mix of bullish and bearish perspectives. The table below offers a condensed view of their ...

Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Integral Ad Science ( (IAS)) just ...

A few months after SK Life Science began rolling out a road trip-themed TV commercial for its antiseizure medication Xcopri, the FDA is attempting to put the brakes on the ad. The regulator late last ...

Integral Ad Science shares dropped more than 10% on Wednesday, after the company reported lackluster revenue growth and softened its guidance for the Q4 season during its quarterly earnings Tuesday ...

Novacap has agreed to acquire Integral Ad Science Holding Corp. in a deal that values the advertising analytics company at about $1.9 billion. The Canadian buyout firm will pay $10.30 a share in cash ...

We came across a bullish thesis on Integral Ad Science Holding Corp. on P14 Capital’s Substack. In this article, we will summarize the bulls’ thesis on IAS. Integral Ad Science Holding Corp.’s share ...